HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma

Peng Liu(Shandong University), Chunhong Ma(Shandong University)

Oncotarget

August 5, 2015

10.18632/oncotarget.4804

Cited by 41

Related Papers

Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers

|Oncogene|2017|373

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA

|Oncotarget|2014|39

<scp>SREBF2–STARD4</scp> axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis

|Cancer Science|2022|36

Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8<sup>+</sup> T Cell Fitness for Antitumor Immunity

|Advanced Science|2024|25